Teladoc Health Inc. (NYSE:TDOC) Q1 2022 Earnings Conference Call April 27, 2022 4:30 PM ET
Company Participants
Patrick Feeley - Head of IR
Jason Gorevic - CEO
Mala Murthy - CFO
Conference Call Participants
Lisa Gill - JPMorgan
Ryan Daniels - William Blair
Sandy Draper - Guggenheim Securities
Sean Dodge - RBC Capital Markets
Richard Close - Canaccord Genuity
Stephanie Davis - SVB Leerink
Daniel Grosslight - Citigroup
Charles Rhyee - Cowen
Jessica Tassan - Piper Sandler
Allen Lutz - Bank of America
George Hill - Deutsche Bank
Stan Berenshteyn - Wells Fargo
Cindy Motz - Goldman Sachs
Operator
Good afternoon. Thank you for attending today's Teladoc 2022 First Quarter Earnings Conference Call. My name is Nate, and I will be your moderator for today's call. All lines have been muted during the presentation portion of the call with an opportunity to questions at the end. [Operator Instructions],
I'd like to now pass the conference over to our host, Patrick Feeley, with Teladoc. Patrick, please go ahead.
Patrick Feeley
Thank you and good afternoon. Today, after the market closed, we issued a press release announcing our first quarter 2022 financial results. This press release and the accompanying slide presentation are available on the Investor Relations section of the teladochealth.com website.
On this call to discuss the results are Jason Gorevic, Chief Executive Officer; and Mala Murthy, Chief Financial Officer. During this call, we will also provide our second quarter and full year 2022 outlook, and our prepared remarks will be followed by a question-and-answer session.
Please note that we will be discussing certain non-GAAP financial measures that we believe are important in evaluating Teladoc Health's performance. Details on the relationship between these non-GAAP measures to the most comparable GAAP measures and reconciliations thereof can be found in the press release that
- Read more current TDOC analysis and news
- View all earnings call transcripts